Retinal angiomatous proliferation

Survey of Ophthalmology

Volumn 62, Issue 4, 2017, Pages 462-492

  Tsai, Andrew S H ^a,b,c   Cheung, Ning ^a,b,c   Gan, Alfred T L ^b   Jaffe, Glenn J ^d   Sivaprasad, Sobha ^e   Wong, Tien Yin ^a,b,c   Cheung, Chui Ming Gemmy ^a,b,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DUKE UNIVERSITY   (United States)

^e MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; anti vascular endothelial growth factor; choroidal neovascularization; fundus fluorescein angiography; optical coherence tomography; photodynamic therapy; pigment epithelial detachment; retinal angiomatous proliferation

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE;

BEST CORRECTED VISUAL ACUITY; BRACHYTHERAPY; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DOPPLER OPTICAL COHERENCE TOMOGRAPHY; EPIMACULAR BRACHYTHERAPY; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; META ANALYSIS; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; PHOTODYNAMIC THERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINAL ANGIOMATOUS PROLIFERATION; RETROSPECTIVE STUDY; REVIEW; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; TRANSPUPILLARY THERMOTHERAPY; WET MACULAR DEGENERATION; CLASSIFICATION; EYE FUNDUS; GLOBAL HEALTH; INCIDENCE; PATHOLOGY; PROCEDURES; RETINA; RETINAL NEOVASCULARIZATION;

FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLOBAL HEALTH; HUMANS; INCIDENCE; RETINA; RETINAL NEOVASCULARIZATION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 85015334079     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2017.01.008     Document Type: Review

References (134)

1. Ahmed, J., Braun, R.D., Dunn, R., Linsenmeier, R.A., Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 34:3 (1993), 516–521.
2. Amarakoon, S., de Jong, J.H., Braaf, B., et al. Phase-resolved Doppler optical coherence tomographic features in retinal angiomatous proliferation. Am J Ophthalmol 160 (2015), 1044–1054.e1.
3. Amselem, L., Díaz-Llopis, M., Cervera, E., García-Delpech, S., Moratal-Peiro, B., Palomares, P., [Intravitreal injection of bevacizumab (Avastin) for retinal angiomatous proliferation]. Arch Soc Esp Oftalmol 83:1 (2008), 53–56.
4. Axer-Siegel, R., Bourla, D., Priel, E., Yassur, Y., Weinberger, D., Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization. Ophthalmology 109:9 (2002), 1726–1736.
5. Bearelly, S., Espinosa-Heidmann, D.G., Cousins, S.W., The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. Br J Ophthalmol 92:2 (2008), 191–196.
6. Borrillo, J.L., Sivalingam, A., Martidis, A., Federman, J.L., Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121:4 (2003), 558–561.
7. Boscia, F., Furino, C., Sborgia, L., Reibaldi, M., Sborgia, C., Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138:6 (2004), 1077–1079.
8. Boscia, F., Parodi, M.B., Furino, C., Reibaldi, M., Sborgia, C., Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 244:10 (2006), 1224–1232.
9. Bottoni, F., Massacesi, A., Cigada, M., Viola, F., Musicco, I., Staurenghi, G., Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123:12 (2005), 1644–1650.
10. Brancato, R., Introini, U., Pierro, L., et al. Optical coherence tomography (OCT) angiomatous prolifieration (RAP) in retinal. Eur J Ophthalmol 12:6 (2002), 467–472.
11. Bressler, N.M., Bressler, S.B., Congdon, N.G., et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 121:11 (2003), 1621–1624.
12. Campa, C., Harding, S.P., Pearce, I.A., Beare, N.A., Briggs, M.C., Heimann, H., Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Eye (Lond) 24:10 (2010), 1585–1589.
13. Caramoy, A., Ristau, T., Lechanteur, Y.T., et al. Environmental and genetic risk factors for retinal angiomatous proliferation. Acta Ophthalmol 92:8 (2014), 745–748.
14. Chakravarthy, U., Wong, T.Y., Fletcher, A., et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol, 10, 2010, 31.
15. Chang, Y.S., Kim, J.H., Yoo, S.J., Lew, Y.J., Kim, J., Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population. Acta Ophthalmol 94 (2016), e49–e53.
16. Chang, L.K., Sarraf, D., Tears of the retinal pigment epithelium: an old problem in a new era. Retina 27:5 (2007), 523–534.
17. Cheng, C.Y., Yamashiro, K., Chen, L.J., et al. New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nat Commun, 6, 2015, 6063.
18. Cho, H.J., Lee, T.G., Han, S.Y., et al. Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 254 (2016), 23–30.
19. Cho, H.J., Yoo, S.G., Kim, H.S., et al. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol 159:2 (2015), 285–292.e1.
20. Clemens, C.R., Eter, N., Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica 235:1 (2016), 1–9.
21. Cohen, S.Y., Creuzot-Garcher, C., Darmon, J., et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 91:9 (2007), 1173–1176.
22. Costagliola, C., Romano, M.R., dell'Omo, R., Cipollone, U., Polisena, P., Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 144:3 (2007), 449–451.
23. Daniel, E., Shaffer, J., Ying, G.S., et al. Outcomes in Eyes with retinal angiomatous proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Ophthalmology 123:3 (2016), 609–616.
24. Dansingani, K.K., Naysan, J., Freund, K.B., En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation). Eye (Lond) 29:5 (2015), 703–706.
25. Donati, M.C., Carifi, G., Virgili, G., Menchini, U., Retinal angiomatous proliferation: association with clinical and angiographic features. Ophthalmologica 220:1 (2006), 31–36.
26. Engelbert, M., Zweifel, S.A., Freund, K.B., “Treat and extend” dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina 29:10 (2009), 1424–1431.
27. Forooghian, F., Cukras, C., Chew, E.Y., Retinal angiomatous proliferation complicated by pigment epithelial tear following intravitreal bevacizumab treatment. Can J Ophthalmol 43:2 (2008), 246–248.
28. Freund, K.B., Ho, I.V., Barbazetto, I.A., et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28:2 (2008), 201–211.
29. Freund, K.B., Klais, C.M., Eandi, C.M., et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124:4 (2006), 487–492.
30. Fritsche, L.G., Chen, W., Schu, M., et al. Seven new loci associated with age-related macular degeneration. Nat Genet 45:4 (2013), 433–439 439e1–439e2.
31. Gass, J.D., Agarwal, A., Lavina, A.M., Tawansy, K.A., Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23:6 (2003), 741–751.
32. Gharbiya, M., Allievi, F., Recupero, V., Martini, D., Mazzeo, L., Gabrieli, C.B., Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 29:6 (2009), 740–749.
33. Gharbiya, M., Parisi, F., Cruciani, F., Bozzoni-Pantaleoni, F., Pranno, F., Abdolrahimzadeh, S., Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen. Retina 34:2 (2014), 298–305.
34. Ghazi, N.G., Knape, R.M., Kirk, T.Q., Tiedeman, J.S., Conway, B.P., Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28:5 (2008), 689–695.
35. Gómez-Ulla, F., Abraldes, M.J., Fernández, M., Olmedo, M., Successful treatment of retinal angiomatous proliferation by photodynamic therapy. Optom Vis Sci 83:8 (2006), 546–549.
36. Gross, N.E., Aizman, A., Brucker, A., Klancnik, J.M., Yannuzzi, L.A., Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25:6 (2005), 713–718.
37. Grunwald, J.E., Daniel, E., Huang, J., et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121:1 (2014), 150–161.
38. Hartnett, M.E., Weiter, J.J., Garsd, A., Jalkh, A.E., Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 230:1 (1992), 11–19.
39. Hartnett, M.E., Weiter, J.J., Staurenghi, G., Elsner, A.E., Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103:12 (1996), 2042–2053.
40. Hayashi, H., Yamashiro, K., Gotoh, N., et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 51:11 (2010), 5914–5919.
41. Heier, J.S., Brown, D.M., Chong, V., et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:12 (2012), 2537–2548.
42. Hemeida, T.S., Keane, P.A., Dustin, L., Sadda, S.R., Fawzi, A.A., Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol 94:6 (2010), 701–705.
43. Hufendiek, K., Panagakis, G., Helbig, H., Gamulescu, M.A., Visual and morphological outcomes of bevacizumab (Avastin®) versus ranibizumab (Lucentis®) treatment for retinal angiomatous proliferation. Int Ophthalmol 32:3 (2012), 259–268.
44. Hunter, M.A., Dunbar, M.T., Rosenfeld, P.J., Retinal angiomatous proliferation: clinical characteristics and treatment options. Optometry 75:9 (2004), 577–588.
45. Inoue, M., Arakawa, A., Yamane, S., Kadonosono, K., Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography. Br J Ophthalmol 98:7 (2014), 956–960.
46. Joeres, S., Heussen, F.M., Treziak, T., Bopp, S., Joussen, A.M., Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:11 (2007), 1597–1602.
47. Johnson, T.M., Glaser, B.M., Focal laser ablation of retinal angiomatous proliferation. Retina 26:7 (2006), 765–772.
48. Kim, J.H., Kim, J.R., Kang, S.W., Kim, S.J., Ha, H.S., Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 155:4 (2013), 743–749 749.e1–749.e2.
49. Kim, Y.K., Park, S.J., Woo, S.J., Park, K.H., Choroidal thickness change after intravitreal anti-vascular endothelial growth factor treatment in retinal angiomatous proliferation and its recurrence. Retina 36:8 (2016), 1516–1526.
50. Koizumi, H., Iida, T., Saito, M., Nagayama, D., Maruko, I., Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 246:4 (2008), 515–520.
51. Kramann, C.A., Schöpfer, K., Lorenz, K., Zwiener, I., Stoffelns, B.M., Pfeiffer, N., Intravitreal ranibizumab treatment of retinal angiomatous proliferation. Acta Ophthalmol 90:5 (2012), 487–491.
52. Krebs, I., Glittenberg, C., Hagen, S., Haas, P., Binder, S., Retinal angiomatous proliferation: morphological changes assessed by Stratus and Cirrus OCT. Ophthalmic Surg Lasers Imaging 40:3 (2009), 285–289.
53. Krieglstein, T.R., Kampik, A., Ulbig, M., Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation. Br J Ophthalmol 90:11 (2006), 1357–1360.
54. Kuehlewein, L., Dansingani, K.K., de Carlo, T.E., et al. Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration. Retina 35:11 (2015), 2229–2235.
55. Kuhn, D., Meunier, I., Soubrane, G., Coscas, G., Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 113:11 (1995), 1392–1398.
56. Kuroiwa, S., Arai, J., Gaun, S., Iida, T., Yoshimura, N., Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 23:3 (2003), 417–420.
57. Lafaut, B.A., Aisenbrey, S., Vanden Broecke, C., Bartz-Schmidt, K.U., Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol 84:11 (2000), 1269–1274.
58. Lee, M.Y., Kim, K.S., Lee, W.K., Combination therapy of ranibizumab and photodynamic therapy for retinal angiomatous proliferation with serous pigment epithelial detachment in Korean patients: twelve-month results. Retina 31:1 (2011), 65–73.
59. Liu, Y., Wen, F., Huang, S., et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 245:10 (2007), 1441–1445.
60. Lo Giudice, G., Gismondi, M., De Belvis, V., Cian, R., Tavolato, M., Galan, A., Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation. Retina 29:7 (2009), 949–955.
61. Ma, L., Li, Z., Liu, K., et al. Association of genetic variants with polypoidal choroidal vasculopathy: a systematic review and updated meta-analysis. Ophthalmology 122:9 (2015), 1854–1865.
62. Mahmood, S., Kumar, N., Lenfestey, P.M., Murjaneh, S., Heimann, H., Harding, S.P., Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: a retrospective review. Eye (Lond) 23:3 (2009), 530–535.
63. Maier, M., Perz, C., Bockmaier, J., Feucht, N., Lohmann, C.P., [Therapy of stage III retinal angiomatous proliferation. Intravitreal ranibizumab injections]. Ophthalmologe 110:12 (2013), 1171–1178.
64. Mantel, I., Ambresin, A., Zografos, L., Retinal angiomatous proliferation treated with a combination of intravitreal triamcinolone acetonide and photodynamic therapy with verteporfin. Eur J Ophthalmol 16:5 (2006), 705–710.
65. Marques, J.P., Laíns, I., Costa, M., et al. Retinal angiomatous proliferation: a quantitative analysis of the fundoscopic features of the fellow eye. Retina 35:10 (2015), 1985–1991.
66. Maruko, I., Iida, T., Oyamada, H., Sugano, Y., Saito, M., Sekiryu, T., Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. Retina 35:4 (2015), 648–654.
67. Maruko, I., Iida, T., Saito, M., Nagayama, D., Saito, K., Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:1 (2007), 15–22.
68. Matsumoto, H., Sato, T., Kishi, S., Tomographic features of intraretinal neovascularization in retinal angiomatous proliferation. Retina 30:3 (2010), 425–430.
69. Matsumoto, H., Sato, T., Morimoto, M., et al. Treat-and-extend regimen with aflibercept for retinal angiomatous proliferation. Retina 36:12 (2016), 2282–2289.
70. McBain, V.A., Kumari, R., Townend, J., Lois, N., Geographic atrophy in retinal angiomatous proliferation. Retina 31:6 (2011), 1043–1052.
71. Mendis, R., Leslie, T., McBain, V., Lois, N., Combined therapy for retinal angiomatous proliferation with intravitreal triamcinolone and argon laser photocoagulation. Br J Ophthalmol 92:8 (2008), 1154–1156.
72. Meyerle, C.B., Freund, K.B., Iturralde, D., et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27:4 (2007), 451–457.
73. Miller, J.W., Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 151:1 (1997), 13–23.
74. Monés, J., Biarnés, M., Badal, J., Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report. Clin Ophthalmol 7 (2013), 1089–1092.
75. Monson, D.M., Smith, J.R., Klein, M.L., Wilson, D.J., Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 126:12 (2008), 1664–1668.
76. Montero, J.A., Fernandez, M.I., Gomez-Ulla, F., Ruiz-Moreno, J.M., Efficacy of intravitreal bevacizumab to treat retinal angiomatous proliferation stage II and III. Eur J Ophthalmol 19:3 (2009), 448–451.
77. Montero, J.A., Ruiz-Moreno, J.M., Sanabria, M.R., Fernandez-Munoz, M., Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation. Br J Ophthalmol 93:2 (2009), 166–170.
78. Mrejen, S., Sarraf, D., Mukkamala, S.K., Freund, K.B., Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina 33:9 (2013), 1735–1762.
79. Nagiel, A., Sarraf, D., Sadda, S.R., et al. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina 35:4 (2015), 638–647.
80. Nakano, S., Honda, S., Oh, H., Kita, M., Negi, A., Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation. Clin Ophthalmol 6 (2012), 277–282.
81. Nakata, M., Yuzawa, M., Kawamura, A., Shimada, H., Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 141:5 (2006), 968–970.
82. Nicolò, M., Ghiglione, D., Lai, S., Calabria, G., Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 244:10 (2006), 1336–1338.
83. Ohkuma, Y., Hayashi, T., Sakai, T., et al. Retinal angiomatous proliferation associated with risk alleles of ARMS2/HTRA1 gene polymorphisms in Japanese patients. Clin Ophthalmol 8 (2014), 143–148.
84. Oishi, A., Tsujikawa, A., Yamashiro, K., et al. One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome. Am J Ophthalmol 159:5 (2015), 853–860.e1.
85. Okamoto, N., Tobe, T., Hackett, S.F., et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:1 (1997), 281–291.
86. Olea, J.L., Sastre, M., Aragón, J.A., Cardona, A., Mateos, J.M., [Treatment of retinal angiomatous proliferation (RAP). A retrospective study]. Arch Soc Esp Oftalmol 82:1 (2007), 27–35.
87. Panagiotidis, D., Karagiannis, D.A., Baltatzis, S., Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 16:2 (2006), 326–329.
88. Park, Y.G., Roh, Y.J., One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages. BMC Ophthalmol, 15(1), 2015, 182.
89. Parodi, M.B., Iacono, P., Menchini, F., et al. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta Ophthalmol 91:3 (2013), 267–273.
90. Petrarca, R., Nau, J., Dugel, P.U., Jackson, T.L., Epimacular brachytherapy for the treatment of retinal angiomatous proliferation. Retin Cases Brief Rep 6:4 (2012), 353–357.
91. Phasukkijwatana, N., Tan, A.C., Chen, X., Freund, K.B., Sarraf, D., Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy. Br J Ophthalmol, 2016 [Epub ahead of print].
92. Politoa, A., Napolitano, M.C., Bandello, F., Chiodini, R.G., The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. Ann Acad Med Singapore 35:6 (2006), 420–424.
93. Querques, G., Avellis, F.O., Querques, L., Massamba, N., Bandello, F., Souied, E.H., Three dimensional spectral domain optical coherence tomography features of retinal-choroidal anastomosis. Graefes Arch Clin Exp Ophthalmol 250:2 (2012), 165–173.
94. Reche-Frutos, J., Calvo-Gonzalez, C., Donate-Lopez, J., et al. Retinal angiomatous proliferation reactivation 6 months after high-dose intravitreal acetonide triamcinolone and photodynamic therapy. Eur J Ophthalmol 17:6 (2007), 979–982.
95. Reche-Frutos, J., Calvo-Gonzalez, C., Pérez-Trigo, S., Fernandez-Perez, C., Donate-Lopez, J., Garcia-Feijoo, J., Ranibizumab in retinal angiomatous proliferation (RAP): influence of RAP stage on visual outcome. Eur J Ophthalmol 21:6 (2011), 783–788.
96. Roth, D.B., Scott, I.U., Gloth, J.M., Green, S.N., Yarian, D.L., Wheatley, M., Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation. Retina 27:9 (2007), 1201–1204.
97. Rouvas, A.A., Chatziralli, I.P., Theodossiadis, P.G., Moschos, M.M., Kotsolis, A.I., Ladas, I.D., Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina 32:6 (2012), 1181–1189.
98. Rouvas, A.A., Papakostas, T.D., Ntouraki, A., Douvali, M., Vergados, I., Ladas, I.D., Angiographic and OCT features of retinal angiomatous proliferation. Eye (Lond) 24:11 (2010), 1633–1642 quiz 43.
99. Saito, M., Iida, T., Kano, M., Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 153:3 (2012), 504–514.e1.
100. Saito, M., Iida, T., Kano, M., Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation. Jpn J Ophthalmol 57:2 (2013), 211–220.
101. Saito, M., Iida, T., Kano, M., Itagaki, K., Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation. Clin Ophthalmol 6 (2012), 1385–1391.
102. Saito, M., Iida, T., Kano, M., Itagaki, K., Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. Jpn J Ophthalmol 60 (2016), 42–50.
103. Saito, M., Shiragami, C., Shiraga, F., Kano, M., Iida, T., Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 149:3 (2010), 472–481.e1.
104. Saito, M., Shiragami, C., Shiraga, F., Nagayama, D., Iida, T., Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 146:6 (2008), 935–941.e1.
105. Sakimoto, S., Gomi, F., Sakaguchi, H., Tano, Y., Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139:5 (2005), 917–918.
106. Sawa, M., Ueno, C., Gomi, F., Nishida, K., Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation. Retina 34:4 (2014), 761–767.
107. Schmidt-Erfurth, U., Kaiser, P.K., Korobelnik, J.F., et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology 121:1 (2014), 193–201.
108. Schmidt-Erfurth, U., Laqua, H., Schlötzer-Schrehard, U., Viestenz, A., Naumann, G.O., Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120:6 (2002), 835–844.
109. Schmidt-Erfurth, U., Waldstein, S.M., Deak, G.G., Kundi, M., Simader, C., Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology 122:4 (2015), 822–832.
110. Scott, A.W., Bressler, S.B., Retinal angiomatous proliferation or retinal anastomosis to the lesion. Eye (Lond) 24:3 (2010), 491–496.
111. Seidel, G., Werner, C., Weger, M., Steinbrugger, I., Haas, A., Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation. Acta Ophthalmol 91:6 (2013), e482–e485.
112. Shimada, H., Kawamura, A., Mori, R., Yuzawa, M., Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:2 (2007), 295–300.
113. Shimada, H., Mori, R., Arai, K., Kawamura, A., Yuzawa, M., Surgical excision of neovascularization in retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 243:6 (2005), 519–524.
114. Shin, J.Y., Yu, H.G., Optical coherence tomography-based ranibizumab monotherapy for retinal angiomatous proliferation in Korean patients. Retina 34:12 (2014), 2359–2366.
115. Shiragami, C., Iida, T., Nagayama, D., Baba, T., Shiraga, F., Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27:2 (2007), 198–203.
116. Shirakata, Y., Shiragami, C., Yamashita, A., Nitta, E., Fujiwara, A., Shiraga, F., One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation. Jpn J Ophthalmol 56:6 (2012), 599–607.
117. Silva, R.M., Cachulo, M.L., Figueira, J., de Abreu, J.R., Cunha-Vaz, J.G., Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245:8 (2007), 1131–1139.
118. Slakter, J.S., Yannuzzi, L.A., Schneider, U., et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107:4 (2000), 742–753 discussion 53–54.
119. Song, S.J., Youm, D.J., Chang, Y., Yu, H.G., Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 16:5 (2009), 304–310.
120. Spaide, R.F., Klancnik, J.M., Cooney, M.J., Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 133:1 (2015), 45–50.
121. Staurenghi, G., Orzalesi, N., La Capria, A., Aschero, M., Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 105:12 (1998), 2297–2305.
122. Steigerwalt, R.D., Pascarella, A., Retinal angiomatous proliferation successfully treated with indocyanine green dye-enhanced photocoagulation. Ophthalmic Surg Lasers Imaging 44 (2010), 1–6.
123. Stewart, M.W., Grippon, S., Kirkpatrick, P., Aflibercept. Nat Rev Drug Discov 11:4 (2012), 269–270.
124. Truong, S.N., Alam, S., Zawadzki, R.J., et al. High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation. Retina 27:7 (2007), 915–925.
125. Tsaousis, K.T., Konidaris, V.E., Banerjee, S., Empeslidis, T., Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy. Graefes Arch Clin Exp Ophthalmol 253:4 (2015), 663–665.
126. van de Moere, A., Kak, R., Sandhu, S.S., Talks, S.J., Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143:4 (2007), 701–704.
127. Viola, F., Mapelli, C., Villani, E., Tresca Carducci, F., Vezzola, D., Ratiglia, R., Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Eye (Lond) 24:8 (2010), 1344–1351.
128. Viola, F., Massacesi, A., Orzalesi, N., Ratiglia, R., Staurenghi, G., Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 29:6 (2009), 732–739.
129. Wegscheider, B.J., Weger, M., Renner, W., et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114:4 (2007), 738–742.
130. Wong, C.W., Wong, T.Y., Cheung, C.M., Polypoidal choroidal vasculopathy in Asians. J Clin Med 4:5 (2015), 782–821.
131. Wong, C.W., Yanagi, Y., Lee, W.K., et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53 (2016), 107–139.
132. Yamazaki, T., Koizumi, H., Yamagishi, T., Kinoshita, S., Subfoveal choroidal thickness in retinal angiomatous proliferation. Retina 34:7 (2014), 1316–1322.
133. Yannuzzi, L.A., Freund, K.B., Takahashi, B.S., Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 28:3 (2008), 375–384.
134. Yannuzzi, L.A., Negrão, S., Iida, T., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:5 (2001), 416–434.